Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Puerto Rican Men with Proven Prostate Cancer

被引:0
作者
Esteban, Ernesto P. [1 ]
Rivera, Adalis [2 ]
Rivera-Rodriguez, Jaileen [2 ]
机构
[1] Univ Puerto Rico, Dept Phys, Jose E Aguiar Ave,Rd 908,Km 1-2, Humacao, PR 00792 USA
[2] Univ Puerto Rico, Biol Dept, Humacao, PR USA
关键词
Prostate cancer; PSA; Puerto Rico; PSA;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: The purpose of this research was to carry out a statistical study (the first such) of prostate-specific antigen (PSA) levels in Puerto Rican men (including residents of Puerto Rico not born on the island) with proven prostate cancer (PC). We also sought to propose new age-specific PSA reference ranges to improve the diagnosis and prognosis of PC. Methods: In order to address our objectives, a PSA statistical analysis of 16,305 Puerto Rican men (from 2004-2012) with proven PC was carried out. Results: For all Puerto Rican PC patients, PSA statistical central measures and variability were determined. For instance, the mean, median, mode, index of dispersion (ID), and interquartile range (IQR) had the values 16.9 ng/mL, 7.2 ng/mL, 4.5 ng/mL, 3.1 ng/mL, and 11.3 ng/mL, respectively. The ID values suggest significant PSA data variability, and the IQR values show that the PSA data are over-dispersed. We found the median age-specific PSA reference ranges and confidence interval (CI) for all Puerto Rican men with proven PC. Also, we obtained the median PSA level and CI of Puerto Rican men with proven PC in 2 ranges (0<PSA <= 4 ng/mL) and (4 ng/mL<PSA<98 ng/mL). Conclusion: The main objectives of this research were achieved. First, a statistical study of PSA levels in Puerto Rican men with proven PC was conducted. Second, 2 new age-specific PSA reference ranges were obtained in order to improve decision making and medical treatment in PC.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 18 条
[1]   Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients [J].
Battikhi, MNG .
PROSTATE CANCER AND PROSTATIC DISEASES, 2003, 6 (03) :256-260
[2]   SCREENING FOR PROSTATIC-CARCINOMA WITH PROSTATE SPECIFIC ANTIGEN [J].
BRAWER, MK ;
CHETNER, MP ;
BEATIE, J ;
BUCHNER, DM ;
VESSELLA, RL ;
LANGE, PH .
JOURNAL OF UROLOGY, 1992, 147 (03) :841-845
[3]   DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
BASLER, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :948-954
[4]  
CONNOLLY D, 2007, EUR UROL SUPPL, V6, P222
[5]   PSA testing: an evolving relationship with prostate cancer screening [J].
Constantinou, J ;
Feneley, MR .
PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) :6-13
[6]  
Crawford ED, 1996, UROLOGY, V47, P863
[7]  
DeAntoni E P, 1997, Oncology (Williston Park), V11, P475
[8]  
Gupta A, 2014, INDIAN J MED RES, V140, P507
[9]  
Ikuerowo S O, 2016, Niger J Surg, V22, P5, DOI 10.4103/1117-6806.169821
[10]   Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: Age-specific reference ranges for total PSA, free PSA, and percent free PSA [J].
Kalish, LA ;
McKinlay, JB .
UROLOGY, 1999, 54 (06) :1022-1027